| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245331 Early detection of mycobacterial disease |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | US6245297 Apparatus and method for transferring small volumes of substances |
| 06/12/2001 | US6245296 Flow immunosensor apparatus |
| 06/12/2001 | US6245295 Sample testing apparatus with high oxygen permeable tape providing barrier for closed reaction chamber |
| 06/12/2001 | US6245244 Method and kit for separating plasma from whole blood |
| 06/12/2001 | US6245215 Membrane based electrochemical test device and related methods |
| 06/12/2001 | US6244214 Concurrent in ovo injection and detection method and apparatus |
| 06/12/2001 | US6244117 Means for trapping contaminants contained in a gas |
| 06/12/2001 | US6244097 Method for measuring without combustion the heat value of fuel gas |
| 06/12/2001 | US6244096 Trace level detection of analytes using artificial olfactometry |
| 06/12/2001 | US6244093 Method and apparatus for calibrating an air monitor using a flow matching valve |
| 06/12/2001 | US6243980 Protease inhibitor assay |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2121506C Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same |
| 06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/08/2001 | CA2325253A1 High-throughput screening of compounds using electrospray ionization mass spectroscopy |
| 06/08/2001 | CA2290722A1 Consensus peptide presenting entities |
| 06/07/2001 | WO2001040969A1 Exson-intron junction determining device, genetic region determining device, and determining method for them |
| 06/07/2001 | WO2001040806A1 Method and control arrangement for controlling sheet-making process |
| 06/07/2001 | WO2001040805A1 Steroid compounds for steroid receptor binding assays |
| 06/07/2001 | WO2001040804A2 Clearance of aberrant protein in correlation with disease |
| 06/07/2001 | WO2001040803A1 Direct screening method |
| 06/07/2001 | WO2001040802A2 Novel protein |
| 06/07/2001 | WO2001040801A2 Diagnosis and treatment for helicobacter pylori induced colic |
| 06/07/2001 | WO2001040800A2 Syk localized at centrosome |
| 06/07/2001 | WO2001040798A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 06/07/2001 | WO2001040797A1 Screening method |
| 06/07/2001 | WO2001040796A2 Glycoarrays on the surface of biochips |
| 06/07/2001 | WO2001040795A2 Method for determining that a product has been organically produced |
| 06/07/2001 | WO2001040790A1 Method and apparatus for making measurements of accumulations of magnetic particles |
| 06/07/2001 | WO2001040788A1 Biosensor |
| 06/07/2001 | WO2001040787A1 Sample discriminating method |
| 06/07/2001 | WO2001040784A2 Sensor accommodated in a housing |
| 06/07/2001 | WO2001040779A1 Method and device for determining the quality of fluids |
| 06/07/2001 | WO2001040778A1 Enhancing surface-generated fluorescence signal emitted by a sample |
| 06/07/2001 | WO2001040771A2 Apparatus and method for analyzing fluids |
| 06/07/2001 | WO2001040761A1 Inert carriers |
| 06/07/2001 | WO2001040758A2 A method for high throughput thermodynamic screening of ligands |
| 06/07/2001 | WO2001040757A2 Resonant optical cavities for high-sensitivity, high-throughput biological sensors and methods |
| 06/07/2001 | WO2001040755A2 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 06/07/2001 | WO2001040520A1 Methods for determining single nucleotide variations and genotyping |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040518A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | WO2001040517A2 Evaluating and predicting clinical outcomes by gene expression analysis |
| 06/07/2001 | WO2001040513A2 Method of diagnosing rheumatoid arthritis and method of treating rheumatoid arthritis |
| 06/07/2001 | WO2001040509A2 Dynamic determination of analytes |
| 06/07/2001 | WO2001040506A1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |
| 06/07/2001 | WO2001040505A1 Method for analysing a sample for the presence of legionella bacteria comprising an immunosensing step |
| 06/07/2001 | WO2001040503A2 Method for identification and quantification of kinase inhibitors |
| 06/07/2001 | WO2001040502A2 Thin layer chromatographic detection of antibiotics |
| 06/07/2001 | WO2001040500A1 Feeding assay for identifying nematicidal compounds |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040475A2 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040466A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040464A1 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/07/2001 | WO2001040462A1 Method for measuring the extent of skin aging and measurement kit |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040454A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 06/07/2001 | WO2001040452A2 Biologically active material |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040447A1 Hiv-1 protease inhibitor resistance assay |
| 06/07/2001 | WO2001040435A2 Method for measuring changes in the gas composition during reaction processes |
| 06/07/2001 | WO2001040312A2 Naive screening method |
| 06/07/2001 | WO2001040310A2 Immobilisation of proteins using a polypeptide segment |
| 06/07/2001 | WO2001040306A1 Human antibodies as detection reagents |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040293A2 Method of modulating proapoptotic and antiapoptotic pathways in cells |
| 06/07/2001 | WO2001040292A1 Antigen-binding fragments specific for tumor associated antigens |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040278A2 Human semaphorin zsmf-16 |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040269A2 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2001040266A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 06/07/2001 | WO2001040265A2 Ligands for a target molecule and a method for indentifying them |
| 06/07/2001 | WO2001040261A1 Method of diagnosing neurodegenerative disease |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040148A2 Systems and methods to facilitate multiple order combinatorial chemical processes |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039780A1 Activation of novel estrogen receptor supports neuronal viability and function |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
| 06/07/2001 | WO2001032912A8 Use of the jak-stat system in cultured cells to trace effects of tested compounds |
| 06/07/2001 | WO2001026547A8 Respiratory nitric oxide meter |
| 06/07/2001 | WO2001023895A3 Thrombotic episode risk assays using oxidized phospholipids |